Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Multiple Myeloma 16Leukemia, Myeloid, Acute 16Myelodysplastic Syndromes 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma 9Leukemia 8Burkitt Lymphoma 8Lymphoma, Non-Hodgkin 7Lymphoma, Follicular 6Hodgkin Disease 6Congenital Abnormalities 6Sarcoma 5Recurrence 5Neoplasms, Plasma Cell 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Lymphocytic, Chronic, B-Cell 5Hematologic Neoplasms 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Mantle-Cell 4Lymphoma, Large B-Cell, Diffuse 4Central Nervous System Neoplasms 4Breast Neoplasms 4Wilms Tumor 3Retinoblastoma 3Neuroblastoma 3Neoplasm Metastasis 3Myeloproliferative Disorders 3Medulloblastoma 3Lymphoma, Large-Cell, Immunoblastic 3Leukemia, Myelomonocytic, Juvenile 3

Interventions

Cyclophosphamide 9fludarabine phosphate 7Cyclosporine 7Peripheral Blood Stem Cell Transplantation 6Mycophenolic Acid 6Busulfan 6Tacrolimus 5Radiotherapy 5Methotrexate 5Antilymphocyte Serum 5Filgrastim 4Cord Blood Stem Cell Transplantation 4Sirolimus 3Methylprednisolone 3Melphalan 3Rituximab 2Moxifloxacin 2Flow Cytometry 2Etoposide 2Cytarabine 2Arsenic Trioxide 2Alemtuzumab 2venetoclax 1trametinib 1ruxolitinib 1regorafenib 1ponatinib 1pertuzumab 1pembrolizumab 1palbociclib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Myelodysplastic-Myeloproliferative Diseases × Granulocyte Colony-Stimulating Factor × Clear all
NCT00281879 2017-09-27

Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer

OHSU Knight Cancer Institute

Phase 2 Terminated
200 enrolled 11 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡